Monday 17 Jun, 2024 03:41 PM
Site map | Locate Us | Login
   TARC board OKs raising upto Rs 750 cr    Coromandel Intl inks MoU with NBSS&LUP to develop soil test in Maharashtra    Alembic Pharma gets USFDA nod for Icatibant injection    Roto Pumps bags order worth Rs 14 cr    Lupin appoints Abdelaziz Toumi as CEO of API CDMO arm    Godawari Power board OKs Rs 301 cr share buyback    IIFL Finance Q4 PAT slides 10% YoY to Rs 373 cr    Bondada Engineering bags contract for supplying GI pole from Bharti Airtel    Zydus Life?s Gujarat facility gets OAI status from USFDA    Jnk India bags order from Reliance Inds    CRISIL reaffirms rating of Gujarat Fluorochemicals with 'stable' outlook    Biocon?s Andhra Pradesh facility gets 3 USFDA observations    Swan Energy board OKs to incorporate subsidiary    RVNL emerges as L-1 bidder for railway project worth Rs 160 cr    RITES inks MoU with DVC for rail infra works 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Auro Pharma's Telangana facility gets ?OAI? classification
25-May-24   17:08 Hrs IST

The United States Food and Drug Administration (USFDA) conducted an inspection the Unit-III, a formulation manufacturing facility of Eugia Pharma Specialities, a wholly owned subsidiary of Auro Pharma, situated at Pashamylaram, Telangana.

Subsequently, the US FDA has determined the inspection classification status of this facility as ?official action indicated (OAI)?.

The company stated that it remains committed to work closely with the US FDA and continues to enhance its compliance on an ongoing basis.

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.

The drug maker reported 90.58% jump in consolidated net profit to Rs 936.29 crore on 13.82% rise in revenue from operations to Rs 7,271.23 crore in Q3 FY24 over Q3 FY23.

The scrip rose 0.51% to end at Rs 1,235.05 on Friday, 24 May 2024.

Powered by Capital Market - Live News
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Span Margin | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures |Rights & Obligations-English| Rights & Obligations-தமிழ் | Anti Money Laundering Policy | E-Voting | CSR Hit Count : 33310291
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd